 Tables   Table S1, 
S. aureus
HisAAC(6')-APH(2'')* pET15b (Boehr, et al., 2001) aph(2")-IIa E. coli pD17-APH(2")-Ib* pDEST17 (Shakya and Wright, 2010 ) aph(2")-IIIa E. gallinarum pAM3606 pET28a (Chow, et al., 1997 ) aph(2")-IVa E. casseliflavius NC95 pET28a (Tsai, et al., 1998) aph(3')-Ia A. baumannii gDNA pET28a (Fournier, et al., 2006 ) aph(3')-IIa S. enterica pGEME182 pET28a (Siregar, et al., 1994) (Lemke, et al., 2005) mphA E. coli pET28a-MPH(2')-I pET28a (Shakya and Wright, 2010 ) mphB E. coli pTZ3716 pET28a (Noguchi, et al., 1996 ) *The same constructs were used as stated in the cited papers. Remaining genes were cloned from the respective sources into the stated plasmid backbones. 24.6 ± 0.9 1.5 ± 0.1 23.5 ± 1.4 25.1 ± 3.7 1.0 ± 0.1 8.1 ± 0.5 23.7 ± 0.7
28.2 ± 3.5 102 ± 13 Tyrphostin 47 -50.3 ± 8.0 59.3 ± 5.6 170 ± 14 -122 ± 13 77.8 ± 7.9
56.7 ± 1.6 16.6 ± 1.8 21.9 ± 1.7
28.6 ± 7.6 6.6 ± 1.0
-29.6 ± 5.8 120 ± 13 25.8 ± 0.8 300 ± 47 -- 
Enzyme APH(3')-Va APH(3")-Ia APH(4)-Ia APH(6)-Ia APH(9)-Ia MPH(2')-Ia MPH(2')-IIa

Ro-31-8220
27.4 ± 1.8 66.7 ± 11.7 7.1 ± 0.1
88.4 ± 8.5 109 ± 10 289 ± 13* -8.8 ± 0.7* --* Enzyme-inhibitor interactions that showed a non-competitive inhibition trend Figures   Fig S1, related to Figure 6 
. Comparison of quercetin bound to APH(2'')-IVa and ATP bound to APH(2'')
Superposition of structures of APH(2'')-IVa-kanamycin-quercetin with APH(2'')-IIa-ATP-streptomycin (PDB code 3HAV) (Young, et al., 2009) Model was generated by using superposition from Figure 1 , apigenin generated from coordinates of quercetin with atoms 3-OH and 3'-OH deleted. Residues R92 from APH(2'')-IIa and P102 from APH(2'')-IVa are in structurally equivalent positions and are shown in sticks. Note that rotamer of APH(2'')-IIa R92 was changed to mtt rotamer (6% natural occurrence according to Coot) from the rotamer in PDB 3HAV (rotamer <1% occurrence).
Supplemental Experimental Procedures
Phylogenetic analysis of AKs. A comprehensive list of 34 known AKs was compiled in order to determine their phylogenetic relationship: APH(2")-Ia (Acc # AAA26865, residues 175-479), APH(2")-IIa (Acc # AAK63040), APH(2")-IIIa (Acc # AAB49832), APH(2")-IVa (Acc # AAC14693), APH(2")-Ie (Acc # AAW59417), APH(3')-Ia (Acc # CAA23656), APH(3')-IIa (Acc # CAA23892), APH(3')-IIb (Acc # AAG07506), APH(3')-IIIa (Acc # CAA24789), APH(3')-IVa (Acc # P00553), APH(3')-Va (Acc # P00555), APH(3')-Vb (Acc # P13250), APH(3')-Vc (Acc # AAB21326), APH(3')-Vd (Acc # YP_482452), APH(3')-VIa (Acc # CAA30578), APH(3')-VIb (Acc # CAF29483), APH(3')-VIIa (Acc # P14508), APH(3')-VIIIa (Acc # AAA26412), APH(3")-Ia (Acc # CAA37605), APH(3")-Ib (Acc # AAA26442), APH(3")-Ic (Acc # ABC68330), APH(4)-Ia (Acc # P00557), APH(4)-Ib (Acc # CAA52372, residues 179 -420), APH(6)-Ia (Acc # P08077), APH(6)-Ib (Acc # P18622), APH(6)-Ic (Acc # CAA25854), APH(6)-Id (Acc # AAA26443), APH(7")-Ia (Acc # P09979), APH(9)-Ia (Acc # AAB58447), APH(9)-Ib (Acc # AAB66655), APH(9)-Ic (Acc # AAD50455), MPH(2')-Ia (Acc # BAA03776), MPH(2')-IIa (Acc # BAA12910), MPH(2')-IIIa (Acc # BAA34540). These were used as indicated in materials and Methods to construct the tree.
Crystallization and structure determination. APH(2'')-IVa was purified as previously described for APH(4)-Ia (Stogios, et al., 2011) . Crystals of the APH(2'')-IVa-kanamycin complex were grown at room temperature using hanging drop vapor diffusion by mixing 2 μL of protein (40 mg/mL) with 2 μL of reservoir solution containing 0.1 M NaCl, 0.1M HEPES pH 7.5, 25% PEG3350 and 1 mM kanamycin (apo form was grown from a solution containing 0.1 M HEPES pH 7.5, 10% PEG 6K, 5% MPD). Quercetin (5 mM in DMSO) was soaked for 4 days into pre-grown crystals of the APH(2'')-IVa-kanamycin complex. All crystals were cryoprotected with paratone.
Diffraction data for apo and kanamycin-bound complexes were collected at 100 K, using synchrotron radiation at beamline 19-ID (Structural Biology Center, Advanced Photon Source, Argonne National Laboratory), at the peak wavelength of the selenium K absorption edge; for the APH(2'')-IVakanamycin-quercetin complex, native diffraction data (Cu-Ka) at 100 K was collected on a Rigaku RAXIS HTC detector at the Structural Genomics Consortium, Toronto. All diffraction data were processed with the HKL3000 package (Minor, et al., 2006) .
Structure of the apo crystal was solved by Single Anomalous Dispersion (SAD) methods using data between 50 and 2.4 Å. ShelxD (Sheldrick, 2008) identified 7 of the 11 selenium sites and density modification and phase refinement were completed with ShelxE. Initial model building was completed with Arp/warp (Langer, et al., 2008) , followed by cycles of TLS-restrained refinement with Refmac (Murshudov, et al., 1997) (TLS groups were residues 1-99 and 100-298), manual building with Coot (Emsley and Cowtan, 2004) , water and solvent building, and geometric checks using the PDB ADIT server. The final model comprises residues 2-296 and sidechains from Glu86, Lys99, Lys155, Lys159, Asp237 and Glu238 were omitted due to missing electron density.
APH(2'')-IVa-kanamycin complex was solved by SAD using data between 50 and 1.96 Å by phenix.autosol (Adams, et al., 2010) . phenix.autosol identified the positions of 16 of the 20 selenium sites. RESOLVE in the phenix.autosol protocol performed density modification, phase refinement and initial model building. Model building and refinement proceeded by iterative cycles of phenix.rebuild, phenix.refine using TLS parameters (same groups as in apo form), Coot manual building, water and solvent building and geometric checks using the PDB ADIT server. In later stages of the refinement, positive F o -F c density was noticed in the aminoglycoside binding sites. Coordinates for kanamycin were obtained from the APH(3')-IIIa-kanamycin-ADP complex (Fong and Berghuis, 2002) . Ligand restraints were generated using the PRODRG server (no energy minimization) (Schuttelkopf and van Aalten, 2004) . The final APH(2'')-IVa-kanamycin complex model comprises residues 3-297 for both chains in the asymmetric unit, with residues 236-237 missing in chain A, and the sidechains of Lys99, Glu184, Lys188, Arg265 missing in chain A, Arg2, Lys11, Gln15, Lys99, Asn109, Lys172 and Arg265 missing in chain B.
APH(2'')-IVa-kanamycin-quercetin complex was solved by Molecular Replacement using Phaser. The final structure of APH(2'')-IVa plus kanamycin (with waters removed) was used as the search model against the native diffraction data from 10 to 4 Å. Positive F o -F c density was noticed in the nucleotidebinding sites of both protein chains, as well as between the two chains at the non-crystallographic symmetry axis. Coordinates for quercetin were added to all three sites, and refinement was executed using phenix.refine, using restraints for the energy-minimized structure of quercetin calculated by the PRODRG server, and manual adjustment using Coot. Occupancy of quercetin bound to chain A was refined by Phenix.
Positions of ligands and inhibitors were supported using a simulated annealing (SA) omit map procedure: omitting atoms from the ligand/inhibitor plus all enzyme sidechains with a 5 Å radius, followed by SA (Cartesian space) using phenix.refine and F o -F c map generation using phenix.maps. Map contour levels are indicated in respective figure legends.
Structure similarity searches performed using the EBI SSM server (Krissinel and Henrick, 2004) . Structural superpositions performed using the EBI SSM server, PyMOL (Delano) and MUSTANG (Konagurthu, et al., 2006) . Structure images were prepared with PyMOL.
Antibiotic rescue factor determination. MICs were determined for E. coli MC1061 expressing the various APHs, on vectors as previously described, according to the CLSI broth microdilution method (CLSI document M7-A5). Plates were set up following the same conditions with the addition of inhibitors at 2.5 and 5x K i at a final DMSO concentration of 1%. Plates were incubated at 37°C with shaking in a Tecan Sunrise (Switzerland) plate reader with measurements at OD 600nm taken every 30 minutes. Readings were corrected for background and the readings at ¼ MIC for antibiotic, 5x K i for inhibitor and 16 hours incubation were used to calculate the ARF.
